Thank you for standing by. My name is Jayel, and I will be your conference operator today. At this time, I would like to welcome everyone to the BioMarin business update. [Operator Instructions] I ...
Good morning, everyone. Thanks for joining us today. We have Microbix here to talk about their Q4 and Year-End Results for 2025. Before we get into those, I don't believe we're going to work off our ...
The n-Lorem Foundation and the EspeRare Foundation announced today a strategic collaboration to expand access in Europe to ...
The United States Department of Justice released transcripts Tuesday of what they said is a series of short videos that ...
Many Americans, it seems, couldn’t hold on to a clear memory of January 6 for even a few years—or couldn’t be bothered to.
Karthik Ramgopal and Daniel Hewlett discuss the evolution of AI at LinkedIn, from simple prompt chains to a sophisticated ...
On this week’s “More To The Story,” Foreign Policy’s Emma Ashford examines how the capture of Venezuelan President Nicolás ...
A recent Delaware Court of Chancery decision explained why a lack of candor resulted in discovery abuses that justified ...
Somtochi Onyekwere explains the architecture of Corrosion, a distributed system designed for low-latency state replication. She shares how Fly.io transitioned from Consul to a gossip-based SQLite ...
Up to 5% of Americans may carry genetic variants associated with cancer risk, according to a cross-sectional analysis.The ...
SEATTLE & TOKYO--(BUSINESS WIRE)--Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM BioLab Co., Ltd. (“PRISM”) to ...
Nucleosomes are barriers to RNA Polymerase II (Pol II) transcribing along gene bodies in eukaryotes. We found that a fragile “tailless nucleosome” could be generated to resolve the Pol II pausing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback